Clinical trial provides hope for Kiwis with one of world's least survivable cancers
Only 8 per cent of pancreatic cancer patients survive longer than five years but a new clinical trial being brought to New Zealand early next year could change that.
Latest Media
Surge in demand for vitamin C during Covid lifts AFT Pharmaceutical sales
In the first seven months of this year, sales of its high-potency vitamin C products were already more than double the amount sold in the whole of last year!
First home buyers on the rise despite soaring house prices
Despite ever-increasing house prices in New Zealand, first home buyers aren’t being deterred, and their numbers are on the rise.
Pancreatic cancer radiotherapy trial hopes to improve low survival rate
Of all the major cancers, pancreatic cancer has the lowest survival rate - just eight percent of those diagnosed with it are expected to live beyond five years.
KiwiSaver accounts at risk if we don't make a will
Angela Vale, CEO of Footprint NZ shines a light on the risks to our KiwiSaver accounts if we don’t make a Will, and the simple way we can fix it.